DRUG · Unmapped registry intervention
LY2127399
Find medicine records ·
Find other trials using this name
Clinical trial
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
NCT01198002
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo Q2W
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo Q4W
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Methotrexate
Normalized identity: methotrexateView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
HoustonTexas, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1SeoulSouth Korea1ClevelandOhio, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1TampaFlorida, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1DenverColorado, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01198002 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.